| Dr Erika Masuda Alford, MD | |
|
1244 N Marine Corps Dr, Tamuning, GU 96913-4308 | |
| (671) 647-8262 | |
| Not Available |
| Full Name | Dr Erika Masuda Alford |
|---|---|
| Gender | Female |
| Speciality | Endocrinology |
| Experience | 18 Years |
| Location | 1244 N Marine Corps Dr, Tamuning, Guam |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043403447 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | M1720 (Guam) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| American Medical Center, Llc | 1759311699 | 16 |
News Archive
The amount of physiotherapy available following hip and knee replacements comes down to a 'postcode lottery' according to new research from the University of East Anglia.
For the first time, researchers at the University of California, San Diego have peered inside a living mouse cell and mapped the processes that power the celebrated health benefits of omega-3 fatty acids. More profoundly, they say their findings suggest it may be possible to manipulate these processes to short-circuit inflammation before it begins, or at least help to resolve inflammation before it becomes detrimental.
Mylan Inc. today announced that its Indian subsidiary, Mylan Pharmaceuticals Private Limited, has entered into an agreement with Gilead Sciences, under which Mylan has been appointed as the exclusive distributor of Sovaldi (sofosbuvir 400mg tablets) and Harvoni (ledipasvir 90mg/sofosbuvir 400 mg tablets) for the treatment of chronic hepatitis C, in India.
American pharmaceutical manufacturer Alpharma Inc. has agreed to pay $42.5 million to resolve False Claims Act allegations in connection with the marketing of the morphine-based drug, Kadian, the Justice Department announced today. The settlement resolves allegations that, between January 1, 2000 and December 29, 2008, Alpharma paid health care providers to induce them to promote or prescribe Kadian, and made misrepresentations about the safety and efficacy of the drug, which is used to treat chronic moderate to severe pain.
Puritan Medical Products, North America's largest manufacturer of single-use specimen collection devices, announced today that it has been granted two new European patents for its high-performance PurFlock® Ultra and HydraFlock® swabs.
› Verified 3 days ago
| Entity Name | American Medical Center, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457329849 PECOS PAC ID: 1759311699 Enrollment ID: O20050819000498 |
News Archive
The amount of physiotherapy available following hip and knee replacements comes down to a 'postcode lottery' according to new research from the University of East Anglia.
For the first time, researchers at the University of California, San Diego have peered inside a living mouse cell and mapped the processes that power the celebrated health benefits of omega-3 fatty acids. More profoundly, they say their findings suggest it may be possible to manipulate these processes to short-circuit inflammation before it begins, or at least help to resolve inflammation before it becomes detrimental.
Mylan Inc. today announced that its Indian subsidiary, Mylan Pharmaceuticals Private Limited, has entered into an agreement with Gilead Sciences, under which Mylan has been appointed as the exclusive distributor of Sovaldi (sofosbuvir 400mg tablets) and Harvoni (ledipasvir 90mg/sofosbuvir 400 mg tablets) for the treatment of chronic hepatitis C, in India.
American pharmaceutical manufacturer Alpharma Inc. has agreed to pay $42.5 million to resolve False Claims Act allegations in connection with the marketing of the morphine-based drug, Kadian, the Justice Department announced today. The settlement resolves allegations that, between January 1, 2000 and December 29, 2008, Alpharma paid health care providers to induce them to promote or prescribe Kadian, and made misrepresentations about the safety and efficacy of the drug, which is used to treat chronic moderate to severe pain.
Puritan Medical Products, North America's largest manufacturer of single-use specimen collection devices, announced today that it has been granted two new European patents for its high-performance PurFlock® Ultra and HydraFlock® swabs.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Erika Masuda Alford, MD 1244 N Marine Corps Dr, Tamuning, GU 96913-4308 Ph: (671) 647-8262 | Dr Erika Masuda Alford, MD 1244 N Marine Corps Dr, Tamuning, GU 96913-4308 Ph: (671) 647-8262 |
News Archive
The amount of physiotherapy available following hip and knee replacements comes down to a 'postcode lottery' according to new research from the University of East Anglia.
For the first time, researchers at the University of California, San Diego have peered inside a living mouse cell and mapped the processes that power the celebrated health benefits of omega-3 fatty acids. More profoundly, they say their findings suggest it may be possible to manipulate these processes to short-circuit inflammation before it begins, or at least help to resolve inflammation before it becomes detrimental.
Mylan Inc. today announced that its Indian subsidiary, Mylan Pharmaceuticals Private Limited, has entered into an agreement with Gilead Sciences, under which Mylan has been appointed as the exclusive distributor of Sovaldi (sofosbuvir 400mg tablets) and Harvoni (ledipasvir 90mg/sofosbuvir 400 mg tablets) for the treatment of chronic hepatitis C, in India.
American pharmaceutical manufacturer Alpharma Inc. has agreed to pay $42.5 million to resolve False Claims Act allegations in connection with the marketing of the morphine-based drug, Kadian, the Justice Department announced today. The settlement resolves allegations that, between January 1, 2000 and December 29, 2008, Alpharma paid health care providers to induce them to promote or prescribe Kadian, and made misrepresentations about the safety and efficacy of the drug, which is used to treat chronic moderate to severe pain.
Puritan Medical Products, North America's largest manufacturer of single-use specimen collection devices, announced today that it has been granted two new European patents for its high-performance PurFlock® Ultra and HydraFlock® swabs.
› Verified 3 days ago
Dr. Pablo Soriano Guzman, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 543 Guma Yuos St., Tamuning, GU 96913 Phone: 671-646-9696 Fax: 671-649-6601 | |
Mr. Romeo M Samonte, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1757 Army Dr, Suite 108, Tamuning, GU 96913 Phone: 671-647-4533 Fax: 671-647-1110 | |
Annakutty Mathew, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 850 Gov. Carlos Camacho Rd., Tamuning, GU 96913 Phone: 671-647-2330 | |
Paul Alfred Muna Aguon, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 850 Gov Carlos G Camacho Rd, Tamuning, GU 96913 Phone: 671-683-8484 | |
Dr. Chen I Huang, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 744 N Marine Corps Dr Ste C110, Tamuning, GU 96913 Phone: 671-777-3305 Fax: 671-647-0878 | |
Dr. Doris Po Lim, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 241 Farenholt Avenue, Oka Bldg., Suite 208, Tamuning, GU 96913 Phone: 671-646-8845 Fax: 671-646-8917 |